A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting

NCT05094128 · clinicaltrials.gov ↗

RECRUITING

Status

352

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondylarthritis (r-axSpA)

Interventions

DRUG: Upadacitinib

Sponsor

AbbVie